Market Cap
₹3,564 Cr.
P/E
41.38
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

11 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
22.92%
3yr Average
28.01%
5yr Average
26.14%
Net Profit Margin
Latest
11.54%
3yr Average
10.97%
5yr Average
9.03%
ROCE
Latest
20.1%
3yr Average
30.27%
5yr Average
33.27%
Debt to Equity
Latest
0.9
3yr Average
0.48
5yr Average
0.73
Market Share
0.05% (as of Jul 22)
Anti-Infectives - Market Share
0.04% (as of May 21)
Anti-Malarial - Market Share
0.03% (as of Nov 21)
Blood Related - Market Share
0.01% (as of Jul 22)
Cardiovascular - Market Share
0.02% (as of Nov 21)
Dermatology - Market Share
0.04% (as of Aug 20)
Endocrinology - Market Share
0.04% (as of Jul 22)
Gastro-Intestinal - Market Share
0.04% (as of Nov 21)
Gynecology - Market Share
0.08% (as of Nov 21)
Pain - Market Share
0.03% (as of Jul 22)
Pharmaceutical Sector - Market Share
0.01% (as of Nov 21)
Respiratory - Market Share
0% (as of Jul 22)
Sex Stimulants - Market Share
0.05% (as of Nov 21)
Stomatological - Market Share
0.29% (as of Nov 21)
Urology - Market Share
0.01% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Shapers
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis